Answer the medical question with the latest evidence.
Draft medical information responses, watch the literature for safety signals and check every claim in a slide against its primary source.
| Section | Content | References |
|---|---|---|
| Question | Can the drug be used in patients with moderate renal impairment? | — |
| Summary | No dose change is needed in moderate impairment. Data in severe impairment are limited. | [1] [2] |
| Clinical data | Exposure rose about 1.3-fold in a dedicated renal study; phase 3 subgroups showed no new signals | [3]–[5] |
| Safety | Label: monitor renal function; two case reports of acute kidney injury in the literature | [6] |
Questions
The questions at this stage.
- What is the published evidence for use in patients with renal impairment?
- Which new case reports mention this adverse event?
- What did this week’s publications say about our drug class?
- Which claims in this deck lack a primary source?
Related use cases
Also at this stage.
The narrower questions teams bring to this stage.
Claim checking
Every claim in a deck or manuscript matched to its primary source, or flagged.
Medical information responses
Standard response letters with references a reviewer can open.
Safety surveillance
New publications and openFDA adverse event reports screened for signals on a schedule.
Publication planning
What has been published on a drug class, by whom, and where the gaps are.
Claim check
Every claim, matched or flagged.
| Claim | Result | Matched to |
|---|---|---|
| Semaglutide cut MACE by 20% | Verified | SELECT trial |
| “First GLP-1 with renal benefit” | Corrected | FLOW trial |
| Dose 2.4 mg weekly | Verified | FDA label |
Applications
What teams build.
Medical information drafting
Draft standard response letters with references a reviewer can check.
Literature surveillance
Screen new publications for safety signals on a schedule.
Claim checkers
Match every claim in a document to its primary source.
For medical affairs
Every claim referenced before it reaches review.
Draft responses and check decks against the primary literature, so review is about judgement, not hunting for sources.